Clinico-pathologic correlation of liver damage in patients treated with 6-mercaptopurine and adriamycin

Autor:	John H. Casey, Victorio Rodriguez, Michael H. Stern, Robert A. Minow, Mario A. Luna
Rok vydání:	1976
Předmět:	Cancer Research medicine.medical_specialty Leukemic Infiltration business.industry medicine.disease Mercaptopurine Gastroenterology Leukemia Endocrinology Oncology Pathologic correlation Refractory Cholestasis Internal medicine Medicine Alkaline phosphatase In patient business medicine.drug
Zdroj:	Cancer. 38:1524-1528
ISSN:	1097-0142 0008-543X
DOI:	10.1002/1097-0142(197610)38:4<1524::aid-cncr2820380413>3.0.co;2-w
Popis:	Eleven adults with refractory leukemia treated with a combination of 6-mercaptopurine and Adriamycin developed hepatic dysfunction manifested by elevations of serum total bilirubin, alkaline phosphatase, and glutamic oxaloacetic transaminase. Liver tissue obtained at necropsy showed intrahepatic cholestasis (eight cases), hepatocellular necrosis (ten cases), leukemic infiltration (two cases), and fatty change (nine cases). Neither this frequency nor severity of hepatocellular destruction has hitherto been associated with 6-mercaptopurine at the dose levels used in this study, nor has Adriamycin previously been found to be hepatotoxic. It is postulated that Adriamycin potentiated the hepatotoxicity of 6-mercaptopurine in these patients.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4401d1d198d9c3431374373a8cd8d79c https://doi.org/10.1002/1097-0142(197610)38:4<1524::aid-cncr2820380413>3.0.co Zobrazit plný text záznamu Plný text